Cellulitis
Cellulitis
Bottom Line
- Empiric coverage for MRSA is not required given the low rates of MRSA in the community and at KGH.
- Intravenous therapy is required for systemic infection or rapidly progressing erythema.
- The presence of “bilateral” cellulitis suggests an etiology other than infection.
Empiric Therapy
- Oral therapy that covers most common pathogens (S. aureus and Group A Streptococcus) – Cephalexin
- Intravenous therapy - Cefazolin